The CDKN2B-CDKN2A gene cluster is commonly deleted in many types of cancer, and the tumor promoting effects of the CDKN2A-encoded p16 and p14 (ARF) tumor suppressors are well studied in melanocytic lesions [11,12,14,40]. The gene discussed is CDKN2A; the disease is cancer.